Home/Filings/4/0001127602-25-012727
4//SEC Filing

Smart Dalton E. III 4

Accession 0001127602-25-012727

CIK 0000310158other

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 4:04 PM ET

Size

8.5 KB

Accession

0001127602-25-012727

Insider Transaction Report

Form 4
Period: 2025-04-25
Smart Dalton E. III
SVP Fin. - Global Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2025-04-25$58.08/sh+5,000$290,40012,039.802 total
  • Sale

    Common Stock

    2025-04-25$82.76/sh4,262$352,7237,777.802 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-04-255,0000 total
    Exercise: $58.08From: 2016-05-01Exp: 2025-04-30Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0002003375

Filing Metadata

Form type
4
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 4:04 PM ET
Size
8.5 KB